Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of Isocitrate Dehydrogenase Mutated Glioblastomas Through Anomaly Detection Analytics.

Neurosurgery - 15 Jul 2021

Taha Birra, Li Taihui, Boley Daniel, Chen Clark C, Sun Ju

Abstract excerpt

BACKGROUND: The rarity of Isocitrate Dehydrogenase mutated (mIDH) glioblastomas relative to wild-type IDH glioblastomas, as well as their distinct tumor physiology, effectively render them "outliers". Specialized tools are needed to identify these outliers. OBJECTIVE: To carefully craft and apply anomaly detection methods to identify mIDH glioblastoma based on radiomic features derived from magnetic resonance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Glioblastoma
Share to Isocitrate Dehydrogenase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Magnetic Resonance Imaging

Share to Mutation

Source

Identifiers

PMID: 33887763
DOI: 10.1093/neuros/nyab130

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detection of Isocitrate Dehydrogenase Mutated Glioblastomas Through Anomaly Detection Analytics.PMID 33887763Read ↗

IDH1 mutation prediction using MR-based radiomics in glioblastoma: comparison between manual and fully automated deep learning-based approach of tumor segmentation.Semantic proximity Read ↗

Two-Stage Training Framework Using Multicontrast MRI Radiomics for IDH Mutation Status Prediction in Glioma.Semantic proximity Read ↗

Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1Semantic proximity Read ↗

Deep-Learning Convolutional Neural Networks Accurately Classify Genetic Mutations in Gliomas.Semantic proximity Read ↗

One class classification-empowered radiomics for noninvasively accurate prediction of glioma isocitrate dehydrogenase mutation using multiparametric magnetic resonance imaging.Semantic proximity Read ↗

Molecular subtype classification of low-grade gliomas using magnetic resonance imaging-based radiomics and machine learning.Semantic proximity Read ↗

Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics.Semantic proximity Read ↗

State of Radiomics in GlioblastomaSemantic proximity Read ↗

Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas.Semantic proximity Read ↗

IDH mutation prediction in non-enhancing gliomas with relaxed T2-FLAIR mismatch and fractal dimension: a two-center study.Semantic proximity Read ↗

Multi-institutional noninvasive in vivo characterization of IDH, 1p/19q, and EGFRvIII in glioma using neuro-Cancer Imaging Phenomics Toolkit (neuro-CaPTk)Semantic proximity Read ↗

Competent Radiogenomics Features for the Prediction of glioma MutationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.